Showing results (181-190 of 469) with videos related to
Sort By:
Pageof 47
The Journal of Rheumatology|February 1, 2025
Tight Control and Radiological Progression: The Radiographic Outcomes of the TICOPA StudyLija James, Philip S Helliwell, Elizabeth M A Hensor, et al.Rheumatology Advances in Practice|February 2, 2026
SpArking change for patients with psoriatic arthritis and axial spondyloarthritis in the UK: results from a UK Delphi consensus studyPhilip S Helliwell, Antoni Chan, David Crosbie, et al.Dermatology (Basel, Switzerland)|February 4, 2012
Linear pitting and splinter haemorrhages are more commonly seen in the nails of patients with established psoriasis in comparison to psoriatic arthritisNatalia Palmou, Helena Marzo-Ortega, Zoe Ash, et al.Yi Chuan Xue Bao = Acta Genetica Sinica|January 1, 1993
[Electrofusion of two-cell embryos of rabbit and their developmental capacity in vitro]L Liu, M AnClinical Biomechanics (Bristol, Avon)|March 26, 2013
Concurrent validation of activity monitors in patients with rheumatoid arthritisMichael R Backhouse, Elizabeth M A Hensor, Derrick White, et al.Rheumatology (Oxford, England)|May 1, 2013
Cost-effectiveness of exercise therapy after corticosteroid injection for moderate to severe shoulder pain due to subacromial impingement syndrome: a trial-based analysisSue Jowett, Dickon P Crawshaw, Philip S Helliwell, et al.Arthritis and Rheumatism|May 12, 2012
Sensitivity and specificity of the classification of psoriatic arthritis criteria in early psoriatic arthritisLaura C Coates, Philip G Conaghan, Paul Emery, et al.BMC Rheumatology|August 31, 2022
Effect of tofacitinib on dactylitis and patient-reported outcomes in patients with active psoriatic arthritis: post-hoc analysis of phase III studiesAna-Maria Orbai, Philip J Mease, Philip S Helliwell, et al.Biopharmaceutics & Drug Disposition|March 1, 1992
A pharmacokinetic and tolerance study of romazarit in patients with rheumatoid arthritisP E Williams, H A Bird, S Minty, et al.Clinical Rheumatology|February 4, 2015
A feasibility study for a randomised controlled trial of treatment withdrawal in psoriatic arthritis (REmoval of treatment for patients in REmission in psoriatic ArThritis (RETREAT (F))Anna Moverley, Laura Coates, Helena Marzo-Ortega, et al.Pageof 47